Sunnybank, thanks for posting great questions, wi
Post# of 2022
wish i did have all of that great info exactly
...
i saw your last question again as well, it was
basically,,,are we being fast tracked.....
...
probably, there are at least two solids answers.
so then, again, may i try another answer, than what i gave beforre,...
that would be, firstly, im almost positive that everything under FDA REGULATION, MUST BE APPROVED BY THEM.
However, they have made a so-called, 'fast-track'
and they have used it to bring forward what they
have considered to prioritize. Pathogen testing has been
fast tracked!!!!!!!!
...
Secondly the ASM has voted to allow the use of any new methods
that arent listed in the laboratory guidebook,
as long as they are certified and benchmarked.
...Thats outside of the FDA for sure, likely its on the fence
or outside of the USDA as well...
However, there is a possibility that the CDC and other bodies
are willing to see what is offered up, just my opinion though
But the ASM is no joke and their members will use
new methods wherever they can, if its 'allowable'.
...
So imo, theres been alot of 'give' in this area
and the MIT1000 just needs to get to that place.
...
Broad market appeal will definitely get it noticed, imo.
...
ok, thats a different probably better answer than the other one..
....
we will have tro see whats going to happen with the FDA....
I know they rule the 'clinical' space.
and we all know NMU is taking us there, even without
Purdue....
so it is definitely going to come up!!!!!!!!!
im betting a five hour test for MRSA can get approval
mmtc rocks!!!
all the best!!!